col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


60 Results       Page 1

 [1] 
Wiley: Vox Sanguinis
  original article Date Title Authors   All Authors
1 [GO] 2022―May―18 Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID -19 pandemic: A Canadian Blood Services Stem Cell Registry analysis David S. Allan, Meagan Green, Gail Morris, Jason Weiss, Nicholas Dibdin, Dena Mercer, Matthew Seftel
2 [GO] 2022―May―17 Reduced neutralizing antibody potency of COVID -19 convalescent vaccinated plasma against SARS-CoV -2 Omicron variant Pierre Gallian, Abdennour Amroun, Syria Laperche, Sophie Le Cam, Nadège Brisbarre, Lucile Malard, et al. (+6)
3 [GO] 2022―Mar―30 Reply to Jacobs et al.: Massive transfusion protocols during the COVID -19 pandemic Chih-Chun Chang, Jen-Tang Sun
4 [GO] 2022―Mar―30 Massive transfusion protocols during the COVID -19 pandemic Jeremy W. Jacobs, Brian D. Adkins, Garrett S. Booth
5 [GO] 2022―Mar―17 Plasma procurement and plasma product safety in light of the COVID -19 pandemic from the perspective of the plasma industry Peter L. Turecek, Deborah Hibbett, Thomas R. Kreil
6 [GO] 2022―Mar―08 International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID -19 pandemic Arwa Z. Al-Riyami, Thierry Burnouf, Erica M. Wood, Dana V. Devine, Adaeze Oreh, Torunn Oveland Apelseth, et al. (+37)
7 [GO] 2022―Feb―03 Impact of COVID -19 on blood donor deferral patterns during the COVID -19 pandemic: A retrospective analysis Suman Sudha Routray, Gopal Krushna Ray, Satya Prakash, Ansuman Sahu, Archana Naik, Somnath Mukherjee
8 [GO] 2022―Jan―13 Are convalescent plasma stocks collected during former COVID-19 waves still effective against current SARS-CoV -2 variants? Daniele Focosi, Massimo Franchini, Michael J. Joyner, Arturo Casadevall
9 [GO] 2022―Jan―13 Psychological impact of the COVID -19 pandemic on young professionals in blood banks and transfusion services: A global cross-sectional survey Arwa Z. Al-Riyami, Barbara Masser, Eszter Herczenik, Satyam Arora, Lilian Antwi Boateng, Carla Luana Dinardo, et al. (+5)
10 [GO] 2021―Dec―28 Does ABO blood group influence antibody response to SARS-CoV -2 vaccination? Costanza Vicentini, Valerio Bordino, Alessandro Roberto Cornio, Davide Meddis, Savina Ditommaso, Monica Giacomuzzi, et al. (+3)
11 [GO] 2021―Dec―13 COVID-19 convalescent plasma: Evolving strategies for serological screening in France Pierre Gallian, Sophie Le Cam, Nadège Brisbarre, Boris Pastorino, Abdennour Amroun, Lucile Malard, et al. (+5)
12 [GO] 2021―Dec―04 Current challenges of severe acute respiratory syndrome coronavirus 2 seroprevalence studies among blood donors: A scoping review Sahar Saeed, Samra Uzicanin, Antoine Lewin, Ryanne Lieshout-Krikke, Helen Faddy, Christian Erikstrup, et al. (+6)
13 [GO] 2021―Nov―24 Active seeking of post-donation information to minimize a potential threat to transfusion safety: A pilot programme in the context of the COVID-19 pandemic Antoine Lewin, Christian Renaud, Amélie Boivin, Marc Germain
14 [GO] 2021―Nov―02 Motivation, blood donor satisfaction and intention to return during the COVID -19 pandemic Christian Weidmann, Marie Derstroff, Harald Klüter, Martin Oesterer, Michael Müller-Steinhardt
15 [GO] 2021―Jun―14 Qualifying coronavirus disease 2019 convalescent plasma donors in Israel Marina Izak, Veronica Gendelman, Sharron Bransburg-Zabary, Evgeniy Stoyanov, Roni Gat, Daniel Cohen, et al. (+6)
16 [GO] 2021―Jun―10 The association of B blood group with SARS-CoV -2-induced death in Babol, north of Iran Saeed Hassani, Narges Kalantari, Seyedeh Farzaneh Jalali, Mahmood Shams, Zahra Ahmadnia, Meysam Aghajani Daroonkola, et al. (+2)
17 [GO] 2021―Jun―09 Management of children with glucose-6-phosphate dehydrogenase deficiency presenting with acute haemolytic crisis during the SARs-COV -2 pandemic Mohsen Elalfy, Amira Adly, Khadiga Eltonbary, Islam Elghamry, Omar Elalfy, Mohamed Maebid, et al. (+3)
18 [GO] 2021―May―20 International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary Arwa Z. Al-Riyami, Thierry Burnouf, Mark Yazer, Darrell Triulzi, Levent Tufan Kumaş, Levent Sağdur, et al. (+62)
19 [GO] 2021―May―20 International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Responses Arwa Z. Al-Riyami, Thierry Burnouf, Mark Yazer, Darrell Triulzi, Levent Tufan Kumaş, Levent Sağdur, et al. (+62)
20 [GO] 2021―Apr―09 Preservation of neutralizing antibody function in COVID-19 convalescent plasma treated using a riboflavin and ultraviolet light-based pathogen reduction technology Susan Yonemura, Lindsay Hartson, Taru S. Dutt, Marcela Henao-Tamayo, Raymond Goodrich, Susanne Marschner
21 [GO] 2021―Apr―09 Blood donation in times of crisis: Early insight into the impact of COVID-19 on blood donors and their motivation to donate across European countries Torsten Chandler, Sebastian Neumann-Böhme, Iryna Sabat, Pedro Pita Barros, Werner Brouwer, Job Exel, et al. (+3)
22 [GO] 2021―Apr―01 COVID-19 convalescent plasma therapy: hit fast, hit hard! Daniele Focosi, Massimo Franchini
23 [GO] 2021―Mar―27 Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic Silvano Wendel, Kevin Land, Dana V. Devine, James Daly, Renée Bazin, Pierre Tiberghien, et al. (+16)
24 [GO] 2021―Mar―18 Impact of pathogen reduction methods on immunological properties of the COVID-19 convalescent plasma Alexander I. Kostin, Maria N. Lundgren, Andrey Y. Bulanov, Elena A. Ladygina, Karina S. Chirkova, Alexander L. Gintsburg, et al. (+14)
25 [GO] 2021―Mar―17 Understanding the role of therapeutic plasma exchange in COVID-19: preliminary guidance and practices Gopal K. Patidar, Kevin J. Land, Hans Vrielink, Naomi Rahimi-Levene, Eldad J. Dann, Hind Al-Humaidan, et al. (+4)
26 [GO] 2021―Mar―02 Anti-A and SARS-CoV-2: an intriguing association Valeria Freitas Dutra, Carolina Bonet-Bub, Ana Paula H. Yokoyama, Ruth Achkar, Rafael Rahal Guaragna Machado, Murilo Assunção, et al. (+15)
27 [GO] 2021―Feb―26 Transfusion profile, clinical characteristics, comorbidities and outcomes of 3014 hospitalized patients diagnosed with COVID-19 in Brazil Leandro Felipe Figueiredo Dalmazzo, Alyne Ferreira Almendra Freitas, Brunna Eulálio Alves, Diogo Kloppel Cardoso, Eduardo Ferro Carvalho, Fabiana Akil, et al. (+11)
28 [GO] 2021―Feb―14 ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group Ruchika Goel, Evan M. Bloch, France Pirenne, Arwa Z. Al-Riyami, Elizabeth Crowe, Laetitia Dau, et al. (+18)
29 [GO] 2021―Feb―06 A survey of laboratory biosafety and protective measures in blood transfusion departments during the COVID-19 pandemic Haiting Liu, Leping Liu, Junhua Zhang, Xueling Shang, Sai Chen, Xisheng Li, et al. (+2)
30 [GO] 2021―Feb―06 Impact of the COVID-19 pandemic on blood supply and demand in the WHO African Region André Loua, Ossy Muganga Julius Kasilo, Jean Baptiste Nikiema, Aissatou Sarassa Sougou, Stanislav Kniazkov, Edith Andrews Annan
31 [GO] 2021―Feb―06 Association of the ABO blood group with SARS-CoV-2 infection in a community with low infection rate Taiwo R. Kotila, Temitope O. Alonge, Adeola Fowotade, Olufisayo I. Famuyiwa, Adebola S. Akinbile
32 [GO] 2021―Jan―25 ABO blood group and SARS-CoV-2 antibody response in a convalescent donor population Evan M. Bloch, Eshan U. Patel, Christi Marshall, Kirsten Littlefield, Ruchika Goel, Brenda J. Grossman, et al. (+12)
33 [GO] 2020―Dec―24 Evaluation of SARS-CoV-2 antibody titers and potency for convalescent plasma donation: a brief commentary Elise Wouters, Maurice Steenhuis, Hubert Schrezenmeier, Pierre Tiberghien, Heli Harvala, Hendrik B. Feys, Ellen Schoot
34 [GO] 2020―Dec―18 Subjects with blood group O are not at lower risk to acquire SARS-CoV-2 infection Nesrine Gamal, Erica Villa, Marco Rolli, Monica Pecorari, Giorgia Mirabella, Elisabetta Bertellini, et al. (+2)
35 [GO] 2020―Dec―13 Trends in blood donations, blood donors’ knowledge, practices and expectations during the COVID-19 pandemic in Cameroon Claude T. Tagny, Isabelle Lendem, Françoise Ngo Sack, Pauline Ngo Balogog, Catherine Ninmou, Ariane Dongmo, et al. (+6)
36 [GO] 2020―Dec―05 Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human plasma Esam I. Azhar, Salwa I. Hindawi, Sherif A. El-Kafrawy, Ahmed M. Hassan, Ahmed M. Tolah, Thamir A. Alandijany, et al. (+2)
37 [GO] 2020―Nov―09 Research initiatives of blood services worldwide in response to the covid-19 pandemic Sheila F. O'Brien, Ryanne W. Lieshout-Krikke, Antoine Lewin, Christian Erikstrup, Whitney R. Steele, Samra Uzicanin, Brian Custer
38 [GO] 2020―Nov―02 Blood transfusion activity in a general hospital during the COVID-19 pandemic Karen Marín-Mori, Isabel González-Gascón y Marín, María-Ángeles Foncillas-García, Carolina Muñoz-Novas, María Infante, Juan Churruca-Sarasqueta, et al. (+4)
39 [GO] 2020―Oct―26 Lack of association between ABO blood groups and susceptibility to SARS-CoV-2 infection José Eduardo Levi, Paulo Roberto Telles, Hommenig Scrivani, Gustavo Campana
40 [GO] 2020―Oct―26 Blood supply management in times of SARS-CoV-2 pandemic - challenges, strategies adopted, and the lessons learned from the experience of a hospital-based blood centre Hem Chandra Pandey, Poonam Coshic, Chippy C S, Priyadarsini Jayachandran Arcot, Karan Kumar
41 [GO] 2020―Sep―30 Blood supply sufficiency and safety management in Iran during the COVID-19 outbreak Mahtab Maghsudlu, Peyman Eshghi, Sedigheh Amini Kafi-Abad, Abbas Sedaghat, Hossein Ranjbaran, Saeed Mohammadi, Seyed Morteza Tabatabai
42 [GO] 2020―Sep―23 Blood group ABO polymorphism inhibits SARS-CoV-2 infection and affects COVID-19 progression Fumiichiro Yamamoto, Miyako Yamamoto, Eduardo Muñiz-Diaz
43 [GO] 2020―Sep―23 Severe acute respiratory syndrome coronavirus-2: implications for blood safety and sufficiency Philip Kiely, Veronica C. Hoad, Clive R. Seed, Iain B. Gosbell
44 [GO] 2020―Sep―19 The protective effect of O blood type against SARS-CoV-2 infection Massimo Franchini, Claudia Glingani, Claudia Del Fante, Martina Capuzzo, Vincenza Di Stasi, Giulia Rastrelli, et al. (+3)
45 [GO] 2020―Jun―15 Blood donation and the global COVID-19 pandemic: areas for social science research Jennie Haw, Kelly Holloway, Barbara M Masser, Eva-Maria Merz, Rachel Thorpe
46 [GO] 2020―Jun―15 Clinical use of Convalescent Plasma in the COVID-19 pandemic; a transfusion-focussed gap analysis with recommendations for future research priorities Arwa Z. Al-Riyami, Richard Schäfer, Karin van der Berg, Evan M Bloch, Lise J. Escourt, Ruchika Goel, et al. (+8)
47 [GO] 2020―Jun―13 Guidance for the Procurement of COVID-19 Convalescent Plasma: Differences between High and Low-Middle Income Countries Evan M. Bloch, Ruchika Goel, Silvano Wendel, Thierry Burnouf, Arwa Z. Al-Riyami, Ai Leen Ang, et al. (+15)
48 [GO] 2020―Jun―09 Vox Sanguinis International Forum on Hospital Transfusion Services’ Response to COVID-19 Massimo Franchini, Giuseppe Marano, Claudio Velati, Ilaria Pati, Simonetta Pupella, Giancarlo Maria Liumbruno
49 [GO] 2020―Jun―09 Early experience with convalescent plasma as immunotherapy for COVID-19 in China: Knowns and unknowns Binzhen Chen, Rong Xia
50 [GO] 2020―May―28 Use of COVID-19 convalescent plasma in low- and middle-income countries: a call for ethical principles and the assurance of quality and safety Jay Epstein, Martin Smid, Silvano Wendel, Daniel Somuah, Thierry Burnouf
51 [GO] 2020―May―14 Vox Sanguinis International Forum on Transfusion Services about Response to COVID-19 Miquel Lozano, Mark Yazer, Bryon Jackson, Monica Pagano, Naomi Rahimi-Levene, Victoria Peer, et al. (+23)
52 [GO] 2020―May―08 Vox Sanguinis International Forum on Transfusion Services about Response to COVID-19 Mark H. Yazer, Bryon Jackson, Monica Pagano, Naomi Rahimi-Levene, Victoria Peer, José Luis Bueno, et al. (+23)
53 [GO] 2020―Apr―29 Impact of COVID-19 on blood centres in Zhejiang province China Yongjun Wang, Wenjuan Han, Lingling Pan, Cuier Wang, Yan Liu, Wei Hu, et al. (+2)
54 [GO] 2020―Apr―22 Points to consider in the preparation and transfusion of COVID-19 convalescent plasma Jay Epstein, Thierry Burnouf
55 [GO] 2020―Apr―20 Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment Shawn D Keil, Izabela Ragan, Susan Yonemura, Lindsay Hartson, Nicole K Dart, Richard Bowen
56 [GO] 2020―Apr―09 Coronavirus-19 Disease (COVID-19) and Decrease in Blood Donation: Experience of Iranian Blood Transfusion Organization (IBTO) Saeed Mohammadi, Seyed Morteza Tabatabaei Yazdi, Peyman Eshghi, Amir Hossein Norooznezhad
57 [GO] 2020―Apr―02 Post-donation COVID-19 identification in blood donors So-Yong Kwon, Eun-Jin Kim, Yu Soek Jung, Jin Sung Jang, Nam-Sun Cho
58 [GO] 2020―Apr―02 Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how Pierre Tiberghien, Xavier de Lambalerie, Pascal Morel, Pierre Gallian, Karine Lacombe, Yazdan Yazdanpanah
59 [GO] 2020―Apr―02 The impact of the SARS-CoV-2 outbreak on the safety and availability of blood transfusions in Italy Massimo Franchini, Albert Farrugia, Claudio Velati, Alessandro Zanetti, Luisa Romanò, Giuliano Grazzini, et al. (+5)
60 [GO] 2020―Jan―13 Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light Markus Eickmann, Ute Gravemann, Wiebke Handke, Frank Tolksdorf, Stefan Reichenberg, Thomas H. Müller, Axel Seltsam
 [1] 

60 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.011 sec